⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SDGR News
Schrodinger, Inc. Common Stock
Form 8-K
sec.gov
SDGR
Form 8-K
sec.gov
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
prnewswire.com
HYFT
SDGR
RXRX
ABSI
CERT
Form 8-K
sec.gov
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Form 8-K
sec.gov
SDGR
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
globenewswire.com
SDGR
Form 8-K
sec.gov
SDGR